Insider Shareholders with Direct Ownership of Iovance Biotherapeutics, Inc. (IOVA)
This section provides a comprehensive overview of the insiders with direct ownership of Iovance Biotherapeutics, Inc. (IOVA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
IOVANCE BIOTHERAPEUTICS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Frederick G Vogt
Interim CEO & General Counsel |
672,816 | 268,212 | 404,604 $704,010 | 33 |
Jun 02, 2025
Reduced 5.19%
|
|
Merrill A Mcpeak
Director |
310,000 | 0 | 320,150 $557,061 | 4 |
Feb 20, 2024
Added 43.85%
|
|
Raj K. Puri
Chief Regulatory Officer |
87,736 | 28,719 | 209,854 $365,145 | 9 |
Jun 02, 2025
Reduced 1.16%
|
|
Michael Weiser
Director |
10,000 | 0 | 112,632 $195,979 | 1 |
May 31, 2022
Added 6.49%
|
|
Finckenstein Friedrich Graf
Chief Medical Officer |
199,102 | 99,942 | 99,160 $172,538 | 34 |
Jun 02, 2025
Reduced 6.11%
|
|
Igor Bilinsky
Chief Operating Officer |
193,908 | 100,275 | 93,633 $162,921 | 34 |
Jun 02, 2025
Reduced 6.26%
|
|
Jean Marc Bellemin
Chief Financial Officer |
128,517 | 67,988 | 60,529 $105,320 | 10 |
Jun 02, 2025
Reduced 6.87%
|
|
Iain D. Dukes
Director |
42,000 | 0 | 54,000 $93,960 | 2 |
Feb 20, 2024
Added 37.21%
|
|
Daniel Gordon Kirby
Chief Commercial Officer |
30,000 | 0 | 30,000 $52,200 | 1 |
Jun 05, 2025
Added 50.0%
|
|
Ryan D Maynard
Director |
57,500 | 50,000 | 7,500 $13,050 | 3 |
Nov 12, 2024
Reduced 86.96%
|